Events
Let’s Connect
The biosimilars community is dedicated to building a healthier future. Let’s come together to share ideas and resources to help increase patient access to biosimilars.
Experiences for Everyone
Biosimilar medicines have the power to help patients at a fraction of the cost of brand biologics. Advocates, scientists, patients and government officials must all join together to raise awareness of biosimilars and break down barriers to access. The Association for Accessible Medicines (AAM) and its Biosimilars Council are thrilled to host events that help promote biosimilars—and we are also proud to participate in events hosted by our partners and friends within the biosimilars community. Scroll to learn more and register for an upcoming event, and help biosimilar medicines reach their greatest potential.
November 2–4, 2026 | Rockville, MD
GRx+Biosims™ 2026 is the leading regulatory, science and policy event for the U.S. generics and biosimilars industry. Access timely information straight from U.S. regulatory experts, grasp the latest policies shaping the industry, and acquire valuable insights to propel your professional development. Join us!
Recent Events
Unable to join a recent live or virtual event? Please watch, listen and share the content below—to learn more about relevant successes and current challenges in the biosimilars industry.
Atlantic Live: The Next Frontier for Accessible Medicines
On November 13, 2024, AAM and its Biosimilars Council’s President & CEO, John Murphy III, joined Senator Peter Welch of Vermont, IQVIA Institute for Human Data Science’s, Murray Aitken, and Apotex USA’s, Christine Baeder, for a discussion on the impact of biosimilars and expanding access. The Washington, DC-based event was moderated by AtlanticLIVE’s, Jeanne Meserve.
Global Biosimilars Week Webinar: Streamlining the Global Regulatory Process
On November 13, 2024, during Global Biosimilars Week, The Center for Biosimilars and the International Generic and Biosimilar Medicines Association hosted a webinar focused on Streamlining the Regulatory Process to Advance Access to Biosimilars across the globe. The event was moderated by the Council’s, Giuseppe Randazzo.
GRx+Biosims 2025 Recap
The 2025 GRx+Biosims Conference set an energetic tone for the year ahead. With a patient-centric message that echoed a recurring theme of “bringing passion to purpose,” speakers reminded attendees that behind every regulation, every manufacturing milestone, and every patent debate is the same mission: helping America’s patients thrive through more affordable medication options.